These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10575561)

  • 21. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
    Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
    Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
    Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
    Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
    Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of efficacy of interferon treatment of chronic hepatitis C and occurrence of HCC after interferon treatment by a new classification.
    Kim KI; Sasase N; Taniguchi M; Mita K; Kim SR; Tanaka K; Hayashi Y
    Intervirology; 2005; 48(1):52-8. PubMed ID: 15785090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
    Poynard T; Ngo Y; Munteanu M; Thabut D; Massard J; Moussalli J; Varaud A; Benhamou Y; Ratziu V
    Antivir Ther; 2010; 15(4):617-31. PubMed ID: 20587855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention and treatment of hepatitis C].
    Poupon R; Serfaty L
    Bull Acad Natl Med; 1996; 180(6):1279-89; discussion 1289-92. PubMed ID: 8991609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon alpha for eradication of HCV and remission of chronic hepatitis in children.
    Majda-Stanisławska E; Szaflik I; Omulecka A
    Med Sci Monit; 2000; 6(6):1142-7. PubMed ID: 11208470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C.
    Bruno S; Battezzati PM; Bellati G; Manzin A; Maggioni M; Crosignani A; Borzio M; Solforosi L; Morabito A; Ideo G; Podda M
    J Hepatol; 2001 May; 34(5):748-55. PubMed ID: 11434622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term course of interferon-treated chronic hepatitis C.
    Cammà C; Di Marco V; Lo Iacono O; Almasio P; Giunta M; Fuschi P; Vaccaro A; Fabiano C; Magrin S; Di Stefano R; Bonura C; Pagliaro L; Craxì A
    J Hepatol; 1998 Apr; 28(4):531-7. PubMed ID: 9566819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCV genotypes and breakthrough in patients treated with recombinant alpha interferon.
    Roffi L; Colloredo G; Brugnetti B; Bellati G; Ricci A; Scalori A; Antonelli G; Panizzuti F; Pozzi M; Pioltelli P; Mancia G
    Am J Gastroenterol; 1998 Sep; 93(9):1602-3. PubMed ID: 9732970
    [No Abstract]   [Full Text] [Related]  

  • 33. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
    Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
    Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of antiviral therapy on the course of chronic HCV infection. A systematic review.
    Almasio PL; Venezia G; Craxì A
    Panminerva Med; 2003 Sep; 45(3):175-82. PubMed ID: 14618115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A sustained response in chronic hepatitis C treated with interferon].
    Ruzza M; Andorno S; Ballarè M; Brondolo R; Cusumano S; D'Andrea F; La Terra G; Occhipinti P; Picchini G; Sartori M
    Recenti Prog Med; 1994 Sep; 85(9):433-7. PubMed ID: 7938875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic hepatitis C: etiology, pathogenesis, treatment].
    Maev IV; Polunina TE; Polunina EV
    Klin Med (Mosk); 2009; 87(11):12-7. PubMed ID: 20143559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and therapy of chronic viral hepatitis].
    Heintges T; Niederau C; Mohr L; Hensel F; Häussinger D
    Z Gastroenterol; 1996 Jul; 34(7):446-56. PubMed ID: 8928540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death.
    Kasahara A; Tanaka H; Okanoue T; Imai Y; Tsubouchi H; Yoshioka K; Kawata S; Tanaka E; Hino K; Hayashi K; Tamura S; Itoh Y; Kiyosawa K; Kakumu S; Okita K; Hayashi N
    J Viral Hepat; 2004 Mar; 11(2):148-56. PubMed ID: 14996350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.
    Veldt BJ; Saracco G; Boyer N; Cammà C; Bellobuono A; Hopf U; Castillo I; Weiland O; Nevens F; Hansen BE; Schalm SW
    Gut; 2004 Oct; 53(10):1504-8. PubMed ID: 15361504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies. A prospective study on 20 patients.
    Cohen P; Nguyen QT; Dény P; Ferrière F; Roulot D; Lortholary O; Jarrousse B; Danon F; Barrier JH; Ceccaldi J; Constans J; Crickx B; Fiessinger JN; Hachulla E; Jaccard A; Seligmann M; Kazatchkine M; Laroche L; Subra JF; Turlure P; Guillevin L
    Ann Med Interne (Paris); 1996; 147(2):81-6. PubMed ID: 8760684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.